 For Appointments
617-726-0531
Fax
617-724-3895
Office Address
Massachusetts General Hospital Cancer Center
Division of Surgical Oncology
55 Fruit Street, YAW 7
Boston, MA 02114
Clinical Interests
Thyroid and Parathyroid Surgery; Adrenal Surgery; Head and Neck Surgery; Endocrine Surgery, Melanoma; Hyperparathyroidism; Thyroid Cancer
Education
MD Degree: Harvard Medical School, Boston, MA, 1996
Postdoctoral Training
Residency: General Surgery, Massachusetts General Hospital, Boston, MA
Fellowship: Endocrine Surgery, Cleveland Clinic Foundation, Cleveland, OH
Research Fellowship: Pediatric Surgical Research Laboratory, Massachusetts General Hospital, Boston, MA
Board Certification
Surgery, 2004
Academic Appointments
Instructor in Surgery, Harvard Medical School
My Publications
Link to PubMed Database
Selected Publications
Stephen AE, Chen KT, Milas M, Siperstein AE. The Coming of Age of Radiation-Induced Hyperparathyroidism: Evolving Patterns of Thyroid and Parathyroid Disease Presentation Following Head and Neck Irradiation. In Press. Stephen AE and Berger DL. Shortened length of stay and hospital cost reduction with implementation of an accelerated clinical care pathway after elective colon resection. Surgery. 133(3): 277-82, 2003.
Stephen AE, Segev DL, Ryan DP, Mullins, ME, Schnitzer JJ, Kim SH, Doody DP. The diagnosis of acute appendicitis in a pediatric population: to CT or not to CT. J Pediatr Surg, 38(3): 367-71, 2003.
Stephen AE, Pearsall LA, Christian BP, Donahoe PK, Vacanti JP, MacLaughlin DT. Highly purified mullerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res, 8(8): 2640-6, 2002.
Stephen AE, Masiakos PT, Segev DL, Vacanti JP, Donahoe PK, and MacLaughlin DT. Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo. Proc Natl Acad Sci U S A., 98(6): 3214-3219, 2001
Stephen AE and Berger DL. Carcinoma in the Porcelain Gallbladder: A Relationship Revisited. Surgery, 129(6): 699-703, 2001. Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange-Asschenfeldt B, Brown LF, Vacanti JP, Detmar M. Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res, 62(7): 2004-12, 2002.
Segev DL, Hoshiya Y, Stephen AE, Hoshiya M, Tran TT, Donahoe PK, Maheswaran S. Mullerian Inhibiting Substance Inhibits Normal Breast Epithelial Cell Proliferation. J Biol Chem, 276(29): 26799-806, 2001.
Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci U S A, 99(1): 239-44, 2002.
Tavakkolizadeh A, Berger UV, Stephen AE, Kim BS, Mooney D, Hediger MA, Ashley SW, Vacanti JP, Whang EE. Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography. Transplantation, 75(2): 181-5, 2003.
Tavakkolizadeh A, Stephen AE, Kaihara S, Mooney DL, Kim BS, Ashley SW, Vacanti JP, Whang EE. Enterocyte dynamics in the tissue-engineered intestine. Gut, 48 (suppl 1): 301, 2001.
Stephen AE, Masiakos PT, Segev DL, Vacanti JP, Donahoe PK, MacLaughlin DT. Tissue Engineered Organs Designed to Regress Abnormal Tissue. Surgical Forum. 2000; 50:309-311.
| 
